BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19145792)

  • 1. Pulmonary adenocarcinoma coexisting with multiple myeloma.
    Kocabay G; Erten N; Tiryaki B; Saka B; Tascioğlu C; Kalayoglu-besisik S
    Tuberk Toraks; 2008; 56(3):369-70. PubMed ID: 19145792
    [No Abstract]   [Full Text] [Related]  

  • 2. Synchronous presentation of multiple myeloma and lung cancer.
    Agarwal R; Gupta R; Bhaskar A; Sharma A; Thulkar S; Kumar L
    J Clin Oncol; 2008 Dec; 26(35):5814-6. PubMed ID: 19001336
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma and adenocarcinoma of the lung.
    Tung R; White WB; McCormick JR
    Conn Med; 1981 Sep; 45(9):555-7. PubMed ID: 7297059
    [No Abstract]   [Full Text] [Related]  

  • 4. Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes.
    Giuliani N; Caramatti C; Roti G; Geata A; Colla S; Bonomini S; Hojden M; La Monica S; Sammarelli G; Lazzaretti M; Craviotto L; Mangoni L; Rizzoli V
    J Clin Oncol; 2003 May; 21(9):1887-8. PubMed ID: 12721268
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
    Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
    Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour metastasis from multiple myeloma in Hickman catheter tract.
    Davidson NG
    Eur J Surg Oncol; 1990 Apr; 16(2):170-1. PubMed ID: 2323411
    [No Abstract]   [Full Text] [Related]  

  • 7. Bortezomib in multiple myeloma: treatment and retreatment. A single center experience.
    Warzocha K; Kraj M; Pogłód R; Kwaśniak B
    Acta Pol Pharm; 2008; 65(6):753-6. PubMed ID: 19172860
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of integrin beta1 expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein and poor outcome in patients with multiple myeloma.
    Kurata M; Nakagawa Y; Yamamoto K; Suzuki K; Kitagawa M
    Am J Hematol; 2008 Sep; 83(9):755-7. PubMed ID: 18615555
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethmoidal adenocarcinoma with lung metastases: diagnosis and multimodal treatment.
    Divisi D; Romualdi P; Garramone M; Di Tommaso S; Alicandri Ciufelli C; Crisci R
    G Chir; 2009 Mar; 30(3):93-5. PubMed ID: 19351458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with VAD of a myelodysplastic syndrome occurring during the course of a smoldering multiple myeloma.
    Cortesão E; Espadana A; Laranjeiro P; Jara M; Orfão A
    Leuk Res; 2009 Jan; 33(1):195-7. PubMed ID: 18511113
    [No Abstract]   [Full Text] [Related]  

  • 11. Unilateral nodular and interstitial infiltrate in a 71-year-old man.
    Smadi T; Kwiatt J; O'Neill W; Varkey B
    Respiration; 2007; 74(5):595-8. PubMed ID: 17159335
    [No Abstract]   [Full Text] [Related]  

  • 12. [Broncho-pulmonary adenocarcinoma].
    Piard F; Camus P
    Ann Pathol; 1993; 13(6):390-404. PubMed ID: 8141932
    [No Abstract]   [Full Text] [Related]  

  • 13. Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy.
    Sekine I; Sumi M; Ito Y; Tanai C; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Jpn J Clin Oncol; 2009 Nov; 39(11):707-12. PubMed ID: 19692418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive phase of multiple myeloma with pulmonary cell infiltrates.
    Garewal H; Durie BG
    JAMA; 1982 Oct; 248(15):1875-6. PubMed ID: 7120608
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracapillary proliferative glomerulonephritis due to heavy chain deposition disease.
    Vedder AC; Weening JJ; Krediet RT
    Nephrol Dial Transplant; 2004 May; 19(5):1302-4. PubMed ID: 15102968
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous involvement in multiple myeloma and bortezomib.
    Siniscalchi A; Fratoni S; Santeusanio G; Del Poeta G; de Fabritiis P; Caravita T
    Ann Hematol; 2009 Nov; 88(11):1137-9. PubMed ID: 19259673
    [No Abstract]   [Full Text] [Related]  

  • 18. Noncrystallized form of immunoglobulin-storing histiocytosis as a cause of chronic lung infiltration in multiple myeloma.
    Chantranuwat C
    Ann Diagn Pathol; 2007 Jun; 11(3):220-2. PubMed ID: 17498598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple myeloma and its incidence in the Hospital Santo Tomás].
    Mendez Pereira G
    Arch Med Panamenos; 1965 Apr; 14(1):3-15. PubMed ID: 5839436
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of multiple myeloma with intrathoracic localization].
    Bariffi F; Illiano A; Romano L; Delle Donne P
    Arch Monaldi; 1978; 33(5-6):352-75. PubMed ID: 555304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.